Delivery Order SPE2DB22D1106-SPE2DB25FFAT7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 7, 2025, for $10,523.69 to supply Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $13,660.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $21,125.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. As a child order under a larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This contract, valued at $19,707.30, represents a competitive award with firm fixed pricing and no set-aside designation. The delivery order is scheduled for completion by August 12, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,184.02 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as...
- The Defense Logistics Agency awarded a delivery order valued at $28,993.50 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAT7Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, valued at $43,062.06 for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Descovy, an antiretroviral medication, exemplifies the company's role in fulfilling military and veteran healthcare pharmaceutical requirements through the DLA Medical Supply Chain. This award demonstrates the contractor's continued capability to meet federal competitive procurement standards while supporting defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 7/30/25 |